Nettle™ & PMDD: What the Research Says + Q&A
When: November 6, 2025 at 12 PM ET
Ticket Price: $15.00 + Eventbrite fees
Please note: Eventbrite has decided not to implement in-app purchases for paid online events. This means tickets must be purchased from a web browser on desktop or mobile. We apologize for the inconvenience.
Event Description: This webinar will explore new research into non-invasive brain stimulation for Premenstrual Dysphoric Disorder (PMDD). We will review the recent study Validation of a Non-Invasive Brain Stimulation Device (Nettle™) to Manage Symptoms of PMDD and discuss what it means for future treatment options.
Following the review, participants attending live have the opportunity to take part in a Q&A with Emilé Radyte, PhD, CEO & Founder of Samphire Neuroscience, and inventor of the Nettle™ device.
After this session, you will:
Understand the neuroscience of PMDD, including the latest research on how cyclical hormone sensitivity impacts brain function and emotional regulation.
Understand the key barriers to accurate PMDD diagnosis, including the need for cycle tracking and symptom overlap with other conditions like ADHD and bipolar disorder.
Evaluate the potential role of the Nettle™ device as a non-invasive, non-hormonal, and non-medication treatment option for PMDD, especially for those who don't respond well to current therapies. This will include an exploration of results from a recent clinical trial assessing Nettle specifically for PMDD, where it is currently approved for pain and mood symptoms.
Identify the challenges and opportunities in integrating new PMDD treatments like Nettle™ into healthcare systems, including the importance of clinician awareness, patient advocacy, and coordinated care pathways.
Intended Audience: Designed for anyone who wants to better understand PMDD with an interest in research, mental health, and emerging health technologies.
Hosted by: IAPMD and Emilė Radytė, PhD
Dr Emilė Radytė is a neuroscientist and science communicator whose work explores how hormonal changes shape brain function, mood, and behavior. A graduate of Harvard and Oxford, her research has focused on psychiatric applications and neurocognitive markers of response to brain stimulation treatments for depression.
She is the co-founder of Samphire Neuroscience, a company on a mission to provide brain-based solutions for women across the lifecycle. Its first product, Nettle™, is a CE-marked at-home neurotechnology device for the relief of menstrual-related pain and mood symptoms. Nettle™ is currently part of a PMDD study led by Queen Mary University of London, now in the reporting phase, and an NHS pilot study for endometriosis-related pain. Emilė is deeply passionate about advancing women’s health and closing the gender gap in neuroscience through evidence-based innovation.
Will this be recorded? Yes, this event will be recorded and a link will be shared with all who register.
Get 15% off Nettle™ with promo code IAPMD15 and give back while you shop! A percentage of every purchase made with this code helps fund IAPMD’s work to support and empower those affected by premenstrual disorders. Purchase the Nettle™ here.
Thanks to the generous support of the Christina Bohn Foundation, we’re able to offer a limited number of complimentary tickets to help make this event accessible to everyone who wishes to join. Please reach out to events@iapmd.org for more information.